BCRF maintains its leadership as the largest nonprofit funder of breast cancer research in 2016!
BCRF announces a new $57-million commitment to breast cancer research for 2016-17, supporting research to more than 250 scientists at leading academic and medical institutions in 14 countries. BCRF funded research spans the entire spectrum of breast cancer, from understanding how a normal cell becomes cancer, to prevention and early detection, to developing new targeted treatments and testing novel combinations in clinical trials, to improving survival and quality of life of patients during and after treatment.
Another way to look at the breakdown of our research portfolio is presented in the pie chart pictured above. This reflects the “Common Scientific Outline” (CSO), a coding system established by the National Cancer Institute and International Cancer Research Partnership that is commonly used by funding agencies. The codes break down the research category accordingly:
- Biology – understanding the basic biology of cancer cells and how they divide, spread and multiply
- Etiology – understanding what causes cancer, how a healthy cell begins to grow uncontrollably and form a cancerous tumor
- Prevention – developing strategies for prevention, understanding cancer risk factors and risk-reduction
- Early diagnosis – developing new tools for cancer detection, diagnosis and prognosis
- Treatment – identifying new targets for treatment, developing new treatments and understanding the mechanisms by which treatments work
- Cancer control, survivorship and outcomes – research into population-level health, quality of life, cancer control at the population level, disparities in health outcomes and improving health outcomes
Using the CSO coding system to categorize BCRF awards provides the framework for evaluating the impact of its research dollars; it’s important as it allows BCRF to compare our grant allocation with other funding agencies such as the National Institutes of Health and other foundations, and to share program data with other funders.